The Valley Desk

ArticleJournal for immunotherapy of cancerPublished

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Receptors, Antigen, T-Cell; Treatment Outcome; Immunotherapy, Adoptive; Registries; Adolescent; Adult; Aged; Middle Aged; Female; Male; Lymphoma, Large B-Cell, Diffuse
PubMed ID
39924174
PubMed Central ID
PMC11808862
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal